Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Article
PubMed
Google Scholar
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32.
Article
PubMed
Google Scholar
Kang HM, Kim GH, Jeon HK, Kim DH, Jeon TY, Park DY, et al. Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer. PLoS ONE. 2017;12:e0180251.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lau E, Ronai ZA. ATF2 - at the crossroad of nuclear and cytosolic functions. J Cell Sci. 2012;125:2815–24.
CAS
PubMed
PubMed Central
Google Scholar
Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer. 2010;10:65–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bruhat A, Cherasse Y, Maurin AC, Breitwieser W, Parry L, Deval C, Jones N, Jousse C, Fafournoux P. ATF2 is required for amino acid-regulated transcription by orchestrating specific histone acetylation. Nucleic Acids Res. 2007;35:1312–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Orozco-Lucero E, Dufort I, Sirard MA. Regulation of ATF1 and ATF2 transcripts by sequences in their 3’ untranslated region in cleavage-stage cattle embryos. Mol Reprod Dev. 2017;84:296–309.
Article
CAS
PubMed
Google Scholar
You Z, Zhou Y, Guo Y, Chen W, Chen S, Wang X. Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma. Oncol Lett. 2016;11:760–6.
Article
CAS
PubMed
Google Scholar
Wang Y, Hu SB, Wang MR, Yao RW, Wu D, Yang L, Chen LL. Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat Cell Biol. 2018;20:1145–58.
Article
CAS
PubMed
Google Scholar
Rudraraju B, Droog M, Abdel-Fatah TM, Zwart W, Giannoudis A, Malki MI, et al. Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer. Breast Cancer Res Treat. 2014;147:295–309.
Article
CAS
PubMed
Google Scholar
Inoue S, Mizushima T, Ide H, Jiang G, Goto T, Nagata Y, Netto GJ, Miyamoto H. ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling. Endocr Connect. 2018;7:1397–408.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu F, Cheng Z, Li X, Li Y, Zhang H, Li J, Liu F, Xu H, Li F. A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells. Mol Ther Nucleic Acids. 2017;8:370–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li M, Zhang D, Ge X, Zhu X, Zhou Y, Zhang Y, Peng X, Shen A. TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation. Exp Cell Res. 2019;376:133–48.
Article
CAS
PubMed
Google Scholar
Kirsch K, Zeke A, Toke O, Sok P, Sethi A, Sebo A, et al. Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38. Nat Commun. 2020;11:5769.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu J, Li K, Wang R, Chen S, Wu J, Li X, Ning Q, Yang G, Pang Y. The interplay between ATF2 and NEAT1 contributes to lung adenocarcinoma progression. Cancer Cell Int. 2020;20:594.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lau E, Kluger H, Varsano T, Lee K, Scheffler I, Rimm DL, Ideker T, Ronai ZA. PKCepsilon promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Cell. 2012;148:543–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Watson G, Ronai ZA, Lau E. ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease. Pharmacol Res. 2017;119:347–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Giannoudis A, Malki MI, Rudraraju B, Mohhamed H, Menon S, Liloglou T, Ali S, Carroll JS, Palmieri C. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast cancer research: BCR. 2020;22:126.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nat Protoc. 2006;1:241–5.
Article
CAS
PubMed
Google Scholar
Liu S, Wang F, Liu J, Jin P, Wang X, Yang L, Xi S. ATF2 partly mediated the expressions of proliferative factors and inhibited pro-inflammatory factors’ secretion in arsenite-treated human uroepithelial cells. Toxicol Res (Camb). 2017;6:468–76.
Article
CAS
Google Scholar
Claps G, Cheli Y, Zhang T, Scortegagna M, Lau E, Kim H, et al. A transcriptionally inactive ATF2 variant drives melanomagenesis. Cell Rep. 2016;15:1884–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee SH, Bahn JH, Whitlock NC, Baek SJ. Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways. Oncogene. 2010;29:5182–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang L, Payton R, Dai W, Lu L. Hyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cells. J Biol Chem. 2011;286:1951–8.
Article
CAS
PubMed
Google Scholar
Cheng SC, Huang WC, S Pang JH, Wu YH, Cheng CY. Quercetin inhibits the production of IL-1β-induced inflammatory cytokines and chemokines in ARPE-19 cells via the MAPK and NF-κB signaling pathways. Int J Mol Sci. 2019;20(12):2957.
Article
CAS
PubMed Central
Google Scholar
Varsano T, Lau E, Feng Y, Garrido M, Milan L, Heynen-Genel S, Hassig CA, Ronai ZA. Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2. Clin Cancer Res. 2013;19:2710–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
An JJ, Shi KJ, Wei W, Hua FY, Ci YL, Jiang Q, Li F, Wu P, Hui KY, Yang Y, Xu CM. The ROS/JNK/ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo. Cell Death Dis. 2013;4:e973.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu DS, Chen C, Wu ZJ, Liu B, Gao L, Yang Q, Chen W, Chen JM, Bao Y, Qu L, Wang LH. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma. J Exp Clin Cancer Res. 2016;35:108.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lau E, Feng Y, Claps G, Fukuda MN, Perlina A, Donn D, Jilaveanu L, Kluger H, Freeze HH, Ronai ZA. The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation. Sci Signal. 2015;8:ra124.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shah M, Bhoumik A, Goel V, Dewing A, Breitwieser W, Kluger H, et al. A role for ATF2 in regulating MITF and melanoma development. PLoS Genet. 2010;6: e1001258.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang S, Gao L, Thakur A, Shi P, Liu F, Feng J, Wang T, Liang Y, Liu JJ, Chen M, Ren H. miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2. Tumour Biol. 2016;37:11177–86.
Article
CAS
PubMed
Google Scholar
Li M, Wu X, Liu N, Li X, Meng F, Song S. Silencing of ATF2 inhibits growth of pancreatic cancer cells and enhances sensitivity to chemotherapy. Cell Biol Int. 2017;41:599–610.
Article
CAS
PubMed
Google Scholar
Bhoumik A, Fichtman B, Derossi C, Breitwieser W, Kluger HM, Davis S, Subtil A, Meltzer P, Krajewski S, Jones N, Ronai Z. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc Natl Acad Sci U S A. 2008;105:1674–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eckert RL, Adhikary G, Young CA, Jans R, Crish JF, Xu W, Rorke EA. AP1 transcription factors in epidermal differentiation and skin cancer. J Skin Cancer. 2013;2013:537028.
Article
PubMed
PubMed Central
Google Scholar
Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, Poeter M, et al. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism. Int J Cancer. 2012;131:E884-96.
Article
PubMed
CAS
Google Scholar
Gozdecka M, Lyons S, Kondo S, Taylor J, Li Y, Walczynski J, Thiel G, Breitwieser W, Jones N. JNK suppresses tumor formation via a gene-expression program mediated by ATF2. Cell Rep. 2014;9:1361–74.
Article
CAS
PubMed
Google Scholar
Gozdecka M, Breitwieser W. The roles of ATF2 (activating transcription factor 2) in tumorigenesis. Biochem Soc Trans. 2012;40:230–4.
Article
CAS
PubMed
Google Scholar
Lau E, Sedy J, Sander C, Shaw MA, Feng Y, Scortegagna M, et al. Transcriptional repression of IFNbeta1 by ATF2 confers melanoma resistance to therapy. Oncogene. 2015;34:5739–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Diring J, Camuzeaux B, Donzeau M, Vigneron M, Rosa-Calatrava M, Kedinger C, Chatton B. A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity. PLoS ONE. 2011;6:e23351.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hsu CC, Hu CD. Critical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity. J Biol Chem. 2012;287:8621–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Suzuki K, Matsubara H. Recent advances in p53 research and cancer treatment. J Biomed Biotechnol. 2011;2011:978312.
PubMed
PubMed Central
Google Scholar
Goh AM, Coffill CR, Lane DP. The role of mutant p53 in human cancer. J Pathol. 2011;223:116–26.
Article
CAS
PubMed
Google Scholar
Liu J, Zhang C, Feng Z. Tumor suppressor p53 and its gain-of-function mutants in cancer. Acta Biochim Biophys Sin (Shanghai). 2014;46:170–9.
Article
CAS
Google Scholar
Gong L, Pan X, Abali GK, Little JB, Yuan ZM. Functional interplay between p53 and Delta133p53 in adaptive stress response. Cell Death Differ. 2019;27(5):1618–32.
Article
PubMed
PubMed Central
CAS
Google Scholar